<DOC>
	<DOC>NCT01040741</DOC>
	<brief_summary>This is an observational safety study of a prophylactic use of Flu Egg Derived Adjuvanted Swine Origin A(H1N1) Vaccine in subjects 6 months of age and older. Subjects may receive either 1 or 2 doses: children and elderly will receive 2 doses and adults will receive either 1 or 2 doses.</brief_summary>
	<brief_title>Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject's age in accordance with the approved product label of the country where the study is conducted Subjects will be vaccinated with Focetria®, independently of this study. Subjects or parent/guardian willing to provide informed consent prior to vaccination administration and complete all of the study, including followup contact • Received any prior H1N1 vaccination</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Pandemic influenza A (H1N1) vaccine</keyword>
	<keyword>Adjuvanted</keyword>
</DOC>